Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

Bolognesi M, Di Pascoli M, Verardo A, Gatta A.

World J Gastroenterol. 2014 Mar 14;20(10):2555-63. doi: 10.3748/wjg.v20.i10.2555. Review.

2.

Pathophysiology of portal hypertension.

Iwakiri Y.

Clin Liver Dis. 2014 May;18(2):281-91. doi: 10.1016/j.cld.2013.12.001. Epub 2014 Feb 25. Review.

3.

Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.

Moleda L, Trebicka J, Dietrich P, Gäbele E, Hellerbrand C, Straub RH, Sauerbruch T, Schoelmerich J, Wiest R.

Gut. 2011 Aug;60(8):1122-32. doi: 10.1136/gut.2010.226407. Epub 2011 Feb 12.

PMID:
21317421
4.

Current concepts on the role of nitric oxide in portal hypertension.

Hu LS, George J, Wang JH.

World J Gastroenterol. 2013 Mar 21;19(11):1707-17. doi: 10.3748/wjg.v19.i11.1707. Review.

5.

Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.

Gatta A, Bolognesi M, Merkel C.

Mol Aspects Med. 2008 Feb-Apr;29(1-2):119-29. Epub 2007 Oct 24. Review.

PMID:
18036654
6.

[Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].

Kim MY, Baik SK.

Korean J Gastroenterol. 2009 Sep;54(3):143-8. Review. Korean.

8.

Pathophysiology and a Rational Basis of Therapy.

Gracia-Sancho J, Maeso-Díaz R, Bosch J.

Dig Dis. 2015;33(4):508-14. doi: 10.1159/000374099. Epub 2015 Jul 6.

PMID:
26159267
9.

Pathophysiology of portal hypertension.

Cichoz-Lach H, Celiński K, Słomka M, Kasztelan-Szczerbińska B.

J Physiol Pharmacol. 2008 Aug;59 Suppl 2:231-8. Review.

10.

[Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].

Gatta A, Bolognesi M, Sacerdoti D, Merkel C.

Ann Ital Med Int. 1996 Oct;11 Suppl 2:39S-47S. Review. Italian.

PMID:
9004819
11.

Nitric oxide and portal hypertension.

González-Abraldes J, García-Pagán JC, Bosch J.

Metab Brain Dis. 2002 Dec;17(4):311-24. Review.

PMID:
12602508
12.

Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.

Bosch J, Pizcueta MP, Fernández M, Feu F, Cirera I, Luca A, García-Pagán JC.

Baillieres Clin Gastroenterol. 1992 Sep;6(3):425-36. Review.

PMID:
1421593
13.

Splanchnic and systemic vasodilatation: the patient.

Tsai MH.

J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S266-71. Review. Erratum in: J Clin Gastroenterol. 2008 May-Jun;42(5):table of contents.

PMID:
17975476
14.
15.

Pathophysiology of portal hypertension.

Gupta TK, Chen L, Groszmann RJ.

Clin Liver Dis. 1997 May;1(1):1-12. Review.

PMID:
15562664
16.

Pathophysiology of portal hypertension.

Bosch J, Pizcueta P, Feu F, Fernández M, García-Pagán JC.

Gastroenterol Clin North Am. 1992 Mar;21(1):1-14. Review.

PMID:
1568769
17.

Hemodynamic changes in splanchnic blood vessels in portal hypertension.

Colle I, Geerts AM, Van Steenkiste C, Van Vlierberghe H.

Anat Rec (Hoboken). 2008 Jun;291(6):699-713. doi: 10.1002/ar.20667. Review.

18.

Mechanisms of extrahepatic vasodilation in portal hypertension.

Hennenberg M, Trebicka J, Sauerbruch T, Heller J.

Gut. 2008 Sep;57(9):1300-14. doi: 10.1136/gut.2007.144584. Epub 2008 Apr 29. Review.

PMID:
18445644
19.

Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.

Afzelius P, Bazeghi N, Bie P, Bendtsen F, Vestbo J, Møller S.

Liver Int. 2011 Oct;31(9):1381-7. doi: 10.1111/j.1478-3231.2011.02576.x. Epub 2011 Jul 5.

PMID:
21745317
20.

[Circulatory dysfunction syndrome associated with liver cirrhosis].

Hartleb M.

Przegl Epidemiol. 2005;59(2):549-58. Review. Polish.

PMID:
16190566

Supplemental Content

Support Center